source
- Roche reports narrow failure of breast cancer pill in Phase 3 trial at ASCORoche updated investors and the oncology community that its experimental breast cancer oral therapy did not meet its primary endpoint in a pivotal Phase 3 study. The data, presented at the America…
- Fulcrum Therapeutics considers sale after FDA blocks sickle cell drug developmentFulcrum Therapeutics announced it is undertaking a strategic review that could lead to a sale after its lead sickle cell candidate, pociredir, was effectively blocked by the FDA. The agency cited…